TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer May 16, 1986